跳至主要内容
临床试验/DRKS00000111
DRKS00000111招募中不适用

Etiology, Epidemiology and Treatment of Diarrhea and Enterocolitis in Hemato-oncological High Risk Patients (EpiDi) - EpiDi

niklinik Köln0 个研究点目标入组 400 人开始时间: 2009年6月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Neutropenia >= 5 days, defined as <500 neutrophils/microL. If no differential blood count available, use <1000 leukocytes/micro

排除标准

  • a)Neutropenia <5 days, defined as <500 neutrophils/microL. If no differential blood count available, use <1000 leukocytes/microL
  • b)Patients with Colitis ulcerosa, Morbus Crohn or other inflammatory diseases of the colon
  • c)Patients with diarrhea at admission
  • d)Patienten, receiving prophylaxis with metronidazole (per os or intravenous) or vancomycin (per os)

研究者

发起方
niklinik Köln

相似试验